PGN-EDODM1

PepGen Receives U.S. FDA Fast Track Designation for PGN-EDODM1 for the Treatment of Myotonic Dystrophy Type 1
BioSpace
Tue, 02/20/24 - 05:49 pm
PepGen
oligonucleotides
PGN-EDODM1
myotonic muscular dystrophy
Awaiting FDA hold letter, PepGen accepts 2nd oligonucleotide is no closer to clinic
Fierce Biotech
Wed, 06/14/23 - 11:30 am
PepGen
oligonucleotide
FDA
myotonic muscular dystrophy
PGN-EDODM1